RHYTHM Biosciences Ltd Total Liabilities

Latest as of December 2025: AU$955.41K AUD ≈ $676.01K USD

RHYTHM Biosciences Ltd total liabilities. Based on the latest financial reports, RHYTHM Biosciences Ltd (RHY) has total liabilities worth AU$955.41K AUD (≈ $676.01K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RHYTHM Biosciences Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of RHYTHM Biosciences Ltd (2017–2025)

Total liabilities of RHYTHM Biosciences Ltd from 2017 to 2025. This chart illustrates how RHYTHM Biosciences Ltd's total liabilities have evolved over time, based on quarterly financial data.

RHYTHM Biosciences Ltd Competitors by Total Liabilities

The table below lists competitors of RHYTHM Biosciences Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Veris Ltd AU:VRS	Australia	AU$34.01 Million
CANADIAN NORTH RESOURCES F:EO0	Germany	€3.30 Million
Everest Metals Corporation Ltd AU:EMC	Australia	AU$1.66 Million
Lion Forest Industries Bhd KLSE:8486	Malaysia	RM161.49 Million
UMS-Neiken Group Bhd KLSE:7227	Malaysia	RM8.43 Million
Vulcan Infrastructure and Power Inc. NASDAQ:VIP	USA	$96.76 Million
88 Energy Ltd AU:88E	Australia	AU$362.67K
Builders Capital Mortgage Corp V:BCF	Canada	CA$23.53 Million

Liability Composition Analysis (2017–2025)

This chart breaks down RHYTHM Biosciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see RHYTHM Biosciences Ltd balance sheet assets.

Liquidity & Leverage Metrics

RHYTHM Biosciences Ltd Total Liabilities Ratios Explained

RHYTHM Biosciences Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.45	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how RHYTHM Biosciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for RHYTHM Biosciences Ltd (2017–2025)

The table below shows the annual total liabilities of RHYTHM Biosciences Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$2.17 Million ≈ $1.54 Million	+233.34%
2024-06-30	AU$651.54K ≈ $461.01K	-64.22%
2023-06-30	AU$1.82 Million ≈ $1.29 Million	+70.87%
2022-06-30	AU$1.07 Million ≈ $754.06K	-21.81%
2021-06-30	AU$1.36 Million ≈ $964.39K	+69.77%
2020-06-30	AU$802.85K ≈ $568.07K	+111.44%
2019-06-30	AU$379.71K ≈ $268.67K	+157.64%
2018-06-30	AU$147.38K ≈ $104.28K	+16.52%
2017-06-30	AU$126.48K ≈ $89.49K	--

About RHYTHM Biosciences Ltd

AU:RHY Australia Diagnostics & Research

Market Cap

$16.01 Million

AU$22.63 Million AUD

Market Cap Rank

#25631 Global

#1101 in Australia

Share Price

AU$0.07

Change (1 day)

+0.00%

52-Week Range

AU$0.06 - AU$0.26

All Time High

AU$2.00